Limbtrox S 1000mg/500mg Injection
Marketer
Limbson Pharmaceuticals LLP
Salt Composition
Ceftriaxone (1000mg) + Sulbactam (500mg)
Overview Limbtrox S 1000mg/500mg Injection
Combiflox, a dual-action injectable medication (1000mg/500mg), combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be under a physician's direct guidance. Strictly adhere to the prescribed dosage schedule; complete the entire course, regardless of symptom improvement, as premature cessation may compromise its effectiveness. Commonly reported side effects include nausea, vomiting, diarrhea, and dyspepsia. Escalating side effects necessitate immediate medical consultation. Seek urgent medical attention for allergic reactions (e.g., rash, pruritus, edema, dyspnea). Disclose all current medications to your doctor prior to commencing treatment. Pregnant or lactating individuals require prior medical consultation. Alcohol consumption should be avoided due to potential additive drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and ample hydration are crucial for optimal recovery. Your doctor may order laboratory and imaging tests to monitor therapeutic response.
Uses of Limbtrox S 1000mg/500mg Injection
Infections caused by bacteria
Major Benefits of Limbtrox S 1000mg/500mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
Common Side effects of Limbtrox S 1000mg/500mg Injection:
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Rash
- Diarrhea
- Increased liver enzymes
- Injection site reactions (pain, swelling, redness)
How to use Limbtrox S 1000mg/500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Limbtrox S 1000mg/500mg Injection works:
Limbtrox S injection (1000mg/500mg) combines the antibiotic ceftriaxone with the beta-lactamase inhibitor sulbactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering bacterial survival. Sulbactam counteracts bacterial resistance mechanisms, thereby boosting ceftriaxone's antibacterial effectiveness.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Limbtrox S 1000mg/500mg Injection presents no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Limbtrox S (1000mg/500mg) is typically deemed safe for pregnant individuals. Preclinical trials using animal models revealed minimal or no harmful effects on fetal development; nevertheless, data from human clinical trials are scarce.
Breast feedingCAUTION
Administering Limbtrox S 1000mg/500mg Injection to breastfeeding mothers requires careful consideration. Lactation should be discontinued for the duration of maternal treatment and until the medication is fully cleared from the mother's system.
DrivingUNSAFE
Administering Limbtrox S 1000mg/500mg Injection can induce drowsiness, blurred vision, and dizziness. Refrain from operating a vehicle should these effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Limbtrox S 1000mg/500mg Injection to individuals with renal impairment. Physician consultation is advised.
LiverCAUTION
Exercise caution when administering Limbtrox S 1000mg/500mg Injection to individuals with severe hepatic impairment; dosage modification may be necessary. A physician's consultation is advised. Dosage alteration for Limbtrox S 1000mg/500mg Injection is not suggested for patients exhibiting mild to moderate liver dysfunction.
What if you forget to take Limbtrox S 1000mg/500mg Injection :
Omit doses of Limbtrox S 1000mg/500mg Injection only after contacting your physician.
Facts to Know About Limbtrox S 1000mg/500mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Antimicrobial Agents |
3,018 People bought this recently